Allison D. Fryer

Allison D. Fryer

Auto-generated profile, based on publicly available information

Allison D. Fryer

Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AAAnne Marie Api
Anne Marie Api
DBD. Belsito
D. Belsito
MBM. Bruze
M. Bruze
PCP. Cadby
P. Cadby
PCP. Calow
P. Calow
DWD.K. Wilcox
D.K. Wilcox

1 July 2006 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
PAPaul Abrams
Paul Abrams
KAKarl‐Erik Andersson
Karl‐Erik Andersson
JBJerry J Buccafusco
Jerry J Buccafusco
CCChristopher Chapple
Christopher Chapple
WGWilliam Chet de Groat
William Chet de Groat
AWAlan J Wein
Alan J Wein

4 July 2005 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TRTirumalai Rangasamy
Tirumalai Rangasamy
JGJia Guo
Jia Guo
WMWayne A. Mitzner
Wayne A. Mitzner
JRJessica Roman
Jessica Roman
ASAnju Singh
Anju Singh
SBShyam Biswal
Shyam Biswal
Oxidative stress has been postulated to play an important role in the pathogenesis of asthma; although a defect in antioxidant responses has been speculated to exacerbate asthma severity, this has been difficult to demonstrate with certainty. Nuclear erythroid 2 p45-related factor 2 (Nrf2) is a redox-sensitive basic leucine zipper transcription factor that is involved in the transcriptional regulation of many antioxidant genes. We show that disruption of the Nrf2 gene leads to severe allergen-driven airway inflammation and hyperresponsiveness in mice. Enhanced asthmatic response as a result of ovalbumin sensitization and challenge in Nrf2-disrupted mice was associated with more pronounced mucus cell hyperplasia and infiltration of eosinophils into the lungs than seen in wild-type littermates. Nrf2 disruption resulted in an increased expression of the T helper type 2 cytokines interleukin (IL)-4 and IL-13 in bronchoalveolar lavage fluid and in splenocytes after allergen challenge. The enhanced severity of the asthmatic response from disruption of the Nrf2 pathway was a result of a lowered antioxidant status of the lungs caused by lower basal expression, as well as marked attenuation, of the transcriptional induction of multiple antioxidant genes. Our studies suggest that the responsiveness of Nrf2-directed antioxidant pathways may act as a major determinant of susceptibility to allergen-mediated asthma.

1 December 1984 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
AFAllison D. Fryer
Allison D. Fryer
JMJennifer Maclagan
Jennifer Maclagan
In anaesthetized guinea‐pigs, gallamine produced a dose‐related potentiation of the bronchoconstriction induced by electrical stimulation of the cervical vagus nerves; (+)‐tubocurarine and suxamethonium lacked this effect. The bronchoconstriction produced by intravenous injection of acetylcholine or histamine, however, was not potentiated by gallamine. Vagally‐induced bradycardia was abolished by gallamine, confirming antagonism of the effect of acetylcholine on muscarinic receptors in the heart. The muscarinic receptor agonist pilocarpine, had the opposite effect to gallamine in the lung as it inhibited vagally‐mediated bronchoconstriction. Pretreatment of guinea‐pigs with either guanethidine or propranolol did not affect the gallamine‐induced potentiation of vagally‐mediated bronchoconstriction. The potentiating effect of gallamine in the lung can be explained by blockade of inhibitory, muscarinic receptors located in the parasympathetic nerves supplying the lungs.

1 April 1993 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DJD B Jacoby
D B Jacoby
GGG J Gleich
G J Gleich
AFA D Fryer
A D Fryer
The effect of human eosinophil major basic protein (MBP) as well as other eosinophil proteins, on binding of [3H]N-methyl-scopolamine ([3H]NMS: 1 x 10(-10) M) to muscarinic M2 receptors in heart membranes and M3 receptors in submandibular gland membranes was studied. MBP inhibited specific binding of [3H]NMS to M2 receptors but not to M3 receptors. MBP also inhibited atropine-induced dissociation of [3H]NMS-receptor complexes in a dose-dependent fashion, demonstrating that the interaction of MBP with the M2 muscarinic receptor is allosteric. This effect of MBP suggests that it may function as an endogenous allosteric inhibitor of agonist binding to the M2 muscarinic receptor. Inhibition of [3H]NMS binding by MBP was reversible by treatment with heparin, which binds and neutralizes MBP. Eosinophil peroxidase (EPO) also inhibited specific binding of [3H]NMS to M2 receptors but not to M3 receptors and inhibited atropine-induced dissociation of [3H]NMS-receptor complexes. On a molar basis, EPO is less potent than MBP. Neither eosinophil cationic protein nor eosinophil-derived neurotoxin affected binding of [3H]NMS to M2 receptors. Thus both MBP and EPO are selective allosteric antagonists at M2 receptors. The effects of these proteins may be important causes of M2 receptor dysfunction and enhanced vagally mediated bronchoconstriction in asthma.

5 September 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MDMatthew G. Drake
Matthew G. Drake
GSGregory D. Scott
Gregory D. Scott
EBEmily D. Blum
Emily D. Blum
KLKatherine M. Lebold
Katherine M. Lebold
ZNZhenying Nie
Zhenying Nie
DJDavid B. Jacoby
David B. Jacoby
Eosinophils increase airway sensory nerve density in humans with asthma and in mice, which promotes airway hyperresponsiveness.